Diagnostic Radioisotopes Market is Estimated to Witness High Growth Owing to Increasing Application of Nuclear Medicine

 

Diagnostic radioisotopes are radioactive materials used as tracers or markers in various diagnostic medical procedures such as positron emission tomography (PET), and single-photon emission computed tomography (SPECT). Diagnostic radioisotopes market estimates the global prevalence of diseases and growing aging population.

Market Dynamics:

The diagnostic radioisotopes market is expected to witness high growth over the forecast period owing to increasing application of nuclear medicine in early disease diagnosis and rising prevalence of chronic diseases such as cancer. According to the American Cancer Society, over 1.9 million new cancer cases are likely to be diagnosed in 2023 and over 609,000 cancer deaths are projected in the United States. Furthermore, technological advancements in diagnostic procedures through combination of radioisotopes with nanotechnology and theranostics are also fueling the market growth during the forecast period. However, short half-life of radioisotopes poses challenge in terms of transportation and inventory management.

Major Drivers Propelling Growth in Demand for Diagnostic Radioisotopes

Increase in prevalence of chronic diseases such as cancer: According to WHO, cancer is one of the leading causes of mortality worldwide with approximately 10 million new cases recorded annually. Diagnostic radioisotopes play a vital role in early detection of tumors which helps in improved disease management and higher chances of recovery. Rising global disease burden coupled with growing awareness about benefits of early diagnosis is estimated to boost market expansion over the coming years.

Advancements in radiotracer drug development: Significant efforts are being directed towards research and development of novel targeted radiotracers which aid in more precise detection and characterization of diseased tissues. Companies are engaged in developing improved compounds for positron emission tomography (PET) and single-photon emission computed tomography (SPECT) scans. Launch of such enhanced diagnostic tools will augment the need for specific radioisotopes in the healthcare industry.

Major Market Restrain Hampering Growth in Diagnostic Radioisotopes Market

Stringent regulations pertaining to radioisotope production and trade: Production of medical radioisotopes requires compliance to strict guidelines set by international regulatory agencies to ensure safety in handling of radioactive materials. Changes in regulations could disrupt supply chains until manufacturers make necessary adjustments. Additionally, international trade faced obstacles due to protectionist import/export policies adopted by some countries which negatively impacts market economics. High dependency on few specialized centers for isotope supply makes the industry vulnerable to political risks as well.

Major Market Opportunity for Growth in Diagnostic Radioisotopes Market

Untapped potential in emerging nations: Developing regions in Asia Pacific and Latin America currently account for a small share of the global diagnostic radiopharmaceutical market. However, their demand is projected to increase substantially over coming years driven by rapid economic development, rising healthcare investments, growing patient access to nuclear medicine facilities and increasing government focus on non-communicable diseases. This presents lucrative business opportunities for market players to establish production sites and supply chain networks in such emerging healthcare markets.

Major Market Trend Influencing Growth in Diagnostic Radioisotopes Market

Increasing shift towards theranostics: Theranostics is an evolving field combining therapy and diagnostics which employs the same pharmaceutical moiety for both applications. Companies are actively pursuing the development of dual-functional radiotracers which can deliver therapeutic radiation directly to diseased sites identified on diagnostic scans. This novel approach could revolutionize management of chronic illnesses and boost clinical efficacy. The rising focus on theranostic radiopharmaceuticals reflects the evolving trend in nuclear medicine technology that is likely to shape future growth trajectories in the diagnostic radioisotopes industry.

Comments

Post a Comment

Popular posts from this blog

Fibrinolytic Therapy is Anticipated to Witness Moderate Growth Owing to Rising Prevalence of Cardiovascular Diseases

Image
The global fibrinolytic therapy market is estimated to be valued at US$ 34.96 Bn in 2024 and is expected to exhibit a CAGR of 3.7% over the forecast period of 2023 to 2030. Fibrinolytic therapy, also called thrombolysis, involves the use of clot-busting drugs to dissolve blood clots and restore blood flow. Rising prevalence of cardiovascular diseases such as heart attacks and strokes has increased the demand for fibrinolytic drugs worldwide. Fibrinolytic therapy improves patient outcomes and recovery rates by dissolving the clots blocking arteries and restoring blood flow to tissues and organs. Key players operating in the fibrinolytic therapy market are Genentech, Inc. (Roche), Bayer AG, Boehringer Ingelheim International GmbH, Pfizer Inc., Bristol Myers Squibb Company, Novartis AG, AstraZeneca PLC, Johnson & Johnson, Daiichi Sankyo Company, Limited, Merck & Co., Inc., Sanofi S.A., Takeda Pharmaceutical Company Limited, Abbott Laboratories, Mallinckrodt Pharmaceuticals, Mitsub...
Read more

Intraocular Lens Market to Witness High Growth Due to Rising Prevalence of Cataract Across Globe

Image
Intraocular lens (IOL) is an artificial lens which is implanted inside eyes during cataract surgery to replace clouded eye lenses. IOL helps enhance vision and provides independence from glasses or contact lenses by helping patients restore clarity of vision. IOLs act as replacement for eye's natural crystalline lens after cataract removal. The global intraocular lens market is mainly driven by rising geriatric population suffering from age-related cataracts across the globe. Cataract is common age-related eye disease, affecting vision and quality of life of elderly people. As per the World Health Organization (WHO), cataracts are the leading cause of blindness globally affecting over 38 million population worldwide. Growing cases of cataract and demand for its minimally invasive surgeries are propelling market growth. The Global intraocular lens market is estimated to be valued at US$ 5,076.1 Mn in 2024 and is expected to exhibit a CAGR of 7.2% over the forecast period 2023 to ...
Read more

Exploring the Frontiers of Healthcare: In Vitro Diagnostics (IVD)

Image
  In today's era of cutting-edge medical technology, the field of diagnostics plays a pivotal role in healthcare. Among the various diagnostic methods available, in vitro diagnostics (IVD) stands out as a cornerstone of modern medicine. IVD encompasses a wide range of tests performed on bodily fluids or tissue samples outside the body, providing valuable insights into a patient's health status and aiding in the diagnosis, treatment, and monitoring of diseases. From routine screenings to complex molecular analyses, IVD has revolutionized medical practice, paving the way for personalized and precise healthcare interventions. Understanding In Vitro Diagnostics : In vitro, Latin for "in glass," denotes tests conducted in a controlled laboratory setting, outside the living organism. In the context of diagnostics, this involves analyzing biological specimens such as blood, urine, saliva, and tissue samples collected from patients. IVD techniques utilize various analytical m...
Read more